🇺🇸 FDA
Pipeline program

Per-Oral Endoscopic Myotomy

CRE-2010.430

Phase 2 other active

Quick answer

Per-Oral Endoscopic Myotomy for Primary Esophageal Motility Disorders Including Achalasia and Hypertensive LES is a Phase 2 program (other) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Primary Esophageal Motility Disorders Including Achalasia and Hypertensive LES
Phase
Phase 2
Modality
other
Status
active

Clinical trials